Search
BridgeBio Oncology Therapeutics Ord Shs
BBOTAdd to Watchlist
3.990USD
-0.170-4.09%
Close 09-24 16:00（ET）
319.64MMarket Cap
19.79P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-4.09%
5 Days
-18.40%
1 Month
-56.35%
6 Months
-54.24%
Year to Date
-68.13%
1 Year
-64.94%
Key Figures
4.150Open
4.700High
46.87KVolume
19.79P/E TTM
LossP/E Dynamic
--Dividend TTM
0.06%Turnover Ratio
4.160Prev. Close
3.900Low
186.24KTurnover
42.11P/E Static
0.86P/B
0.00%Div Yield TTM
2.44%ROA
14.87052wk High
28.87Volume Ratio
7.60MNet Profit
80.11MShares
0.2019EPS TTM
--Beta
2.53%ROE
4.05052wk Low
19.23%Amplitude
--Gross Margin
319.64MMarket Cap
1.83Reward/Risk
4.37%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
BridgeBio Oncology Therapeutics Ord Shs Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.71/-0.57
Revenue / Forecast
--/0.00
Ownership
| Shareholders | Proportion |
|---|---|
| Cormorant Asset Management, LP | 22.32% |
| BridgeBio Pharma, Inc. | 18.21% |
| Deerfield Management Company, L.P. | 6.10% |
| BC Global Opportunities IX LP | 5.45% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 42.35% |
| Corporation | 26.94% |
| Investment Advisor/Hedge Fund | 11.53% |
| Venture Capital | 10.63% |
Related Instruments
+2.68%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%
FAQs
What is the current price of BridgeBio Oncology Therapeutics Ord Shs (BBOT)?
The current price of BridgeBio Oncology Therapeutics Ord Shs (BBOT) is 3.99.
What is the symbol of BridgeBio Oncology Therapeutics Ord Shs?
The ticker symbol of BridgeBio Oncology Therapeutics Ord Shs is BBOT.
What is the 52-week high of BridgeBio Oncology Therapeutics Ord Shs?
The 52-week high of BridgeBio Oncology Therapeutics Ord Shs is 14.87.
What is the 52-week low of BridgeBio Oncology Therapeutics Ord Shs?
The 52-week low of BridgeBio Oncology Therapeutics Ord Shs is 3.90.
What is the market capitalization of BridgeBio Oncology Therapeutics Ord Shs?
The market capitalization of BridgeBio Oncology Therapeutics Ord Shs is 319.64M.
Is BridgeBio Oncology Therapeutics Ord Shs (BBOT) currently rated as Buy, Hold, or Sell?
According to analysts, BridgeBio Oncology Therapeutics Ord Shs (BBOT) has an overall rating of Buy, with a price target of 21.89.
What is the Earnings Per Share (EPS TTM) of BridgeBio Oncology Therapeutics Ord Shs (BBOT)?
The Earnings Per Share (EPS TTM) of BridgeBio Oncology Therapeutics Ord Shs (BBOT) is 0.20.